Can Eli Lilly Stock Reach $1800 by 2030? Here Is the Bull Case

Eli Lilly (NYSE:LLY) is growing like a software company. Q1 2026 revenue hit $19.80B, up 55.5% year over year, with Mounjaro ...

Eli Lilly’s Retatrutide Delivers Bariatric-Style Weight Loss In Obesity Trial — Stock Rises Pre-Market

Eli Lilly said its retatrutide cleared a late-stage trial in patients with obesity, with some of them shedding a third of ...
Pharmaceutical Technology on MSN

Eli Lilly maintains M&A streak with $202m Engage Bio buyout

Lilly’s takeover of Engage Bio marks the seventh acquisition for the big pharma since the start of 2026.

High Court Rejects Eli Lilly’s Challenge to $193 Million Award

The US Supreme Court said Monday it won’t review Eli Lilly and Co.'s challenge to a $193 million Medicaid drug fraud judgment in a whistleblower’s False Claims Act suit.

Glucagon-Like Peptide (GLP)-1 Agonists Weight Loss Drugs Market Report 2026 Featuring Major Players Novo Nordisk A/S, Eli Lilly and Company, and Pfizer - Globa…

The GLP-1 agonists weight loss drugs market offers growth potential through rising obesity rates, innovative drug approvals, ...
Fierce Pharma

Lilly accuses church-linked pharmacies, wholesalers and more of running $200M+ rebate fraud scheme

A web of mail-order pharmacies, wholesalers and patient services groups connected to the self-styled largest Pentecostal ...
Christianity Today

Eli Lilly Sues COGIC Leaders Over Alleged $200 Million Drug Rebate Scheme

Pharmaceutical giant Eli Lilly and Company has filed a civil suit alleging four leaders in the Church of God in Christ (COGIC) helped facilitate a fraudulent drug rebate scheme that cost the drug ...

Lilly to showcase oncology portfolio across tumor types and treatment modalities at the 2026 American Society of Clinical Oncology Annual Meeting

Eli Lilly and Company (NYSE: LLY) today announced the details of presentations from across its oncology portfolio at the ...